Atopic dermatitis
Conditions
Interventions
experimental group:the Chinese medicine granules Pei Tu Qing Xin
Control group:Placebo
Sponsors
Second Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
2 Years to 12 Years
Inclusion criteria
Inclusion criteria: Screening criteria: 1. The aged from 2 to 12 years old; 2. Clinical diagnosis meets Hanifin and Rajka AD criteria; 3. IGA score is more than 2 (IGA score> 2); 4. The time without medication is less than 3 months each year; Inclusion criteria: 1. The age is from 2 to 12 years old; 2. Clinical diagnosis meets Hanifin and Rajka AD criteria; 3. The IGA score is less than 2 (IGA score > 2) after treatment of the screening period; 4. Informed consent (or by guardian for those minors).
Exclusion criteria
Exclusion criteria: 1. The patient is one of the investigators of this study; 2. Have used hormone or immunosuppressant in 2 week; 3. Patients can not complete the whole process of the study; 4. Have participated in other AD clinical trail in the current or a month ago; 5. Have significant abnormalities in the blood system, liver, kidney, heart and other system, or complicated with severe primary diseases of the cardiovascular, liver, kidney, brain and hematopoietic system; or suffering from mental disorders, malignant neoplasm; or combined with other skin disease; 6. Acute asthma exacerbation or other diseases that need to use hormone for the maintenance treatment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The starting point of the relapse time; | — |
Secondary
| Measure | Time frame |
|---|---|
| To evaluate the major signs and subjective symptom;The Dermatitis Family Impact questionnaire;total amount of topical fluticasone propionate cream; | — |
Countries
China
Contacts
Public ContactDa-can Chen
Outcome results
None listed